Fig. 2.

Proportions of patients with ≥ 1, ≥ 2, or ≥ 3 (A) all-cause and (B) spasticity-related emergency department visits or hospital admissions during the 12 months before and after onabotulinumtoxinA treatment for post-stroke spasticity.